Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib Meeting Abstract


Authors: Fox, J. J.; Haupt, E. C.; Humm, J.; Autio, K. A.; Rathkopf, D. E.; Vargas, H. A.; Schöder, H.; Hricak, H.; Larson, S. M.; Scher, H. I.; Morris, M. J.
Abstract Title: Post-treatment alterations in 18F-dihydrotestosterone (FDHT) and FDG PET/CT in metastatic castration-resistant prostate cancer (mCRPC) treated with cabozantinib
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419601671
PROVIDER: wos
DOI: 10.1200/jco.2013.31.15_suppl.5073
Notes: Meeting Abstract: 5073 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Josef J Fox
    71 Fox
  2. Michael Morris
    579 Morris
  3. Karen Anne Autio
    120 Autio
  4. Heiko Schoder
    546 Schoder
  5. Dana Elizabeth Rathkopf
    273 Rathkopf
  6. Hedvig Hricak
    421 Hricak
  7. John Laurence Humm
    434 Humm
  8. Steven M Larson
    959 Larson
  9. Howard Scher
    1130 Scher
  10. Eric C Haupt
    8 Haupt